Ankur A. Dashputre
YOU?
Author Swipe
View article: Long-term Patiromer Use and Outcomes Among US Veterans With Hyperkalemia and CKD: A Propensity-Matched Cohort Study
Long-term Patiromer Use and Outcomes Among US Veterans With Hyperkalemia and CKD: A Propensity-Matched Cohort Study Open
Hyperkalemia is a common complication of chronic kidney disease (CKD) and can result in the discontinuation of renin-angiotensin-aldosterone system inhibition therapy, a cornerstone of CKD management. Patiromer is a new potassium binder ap…
View article: A Systematic Literature Review and Network Meta-Analysis of Comparative Efficacy of Topical Fixed-Dose Combination Treatments for Moderate to Severe Acne Vulgaris
A Systematic Literature Review and Network Meta-Analysis of Comparative Efficacy of Topical Fixed-Dose Combination Treatments for Moderate to Severe Acne Vulgaris Open
INTRODUCTION: Several topical and oral monotherapies/combination treatments are available for treating patients with moderate to severe acne vulgaris and a few are currently under review with the United States (US) Food and Drug Administra…
View article: Development of a Patient Reported Outcome Daily Diary to Assess Symptom Burden in Sickle Cell Disease
Development of a Patient Reported Outcome Daily Diary to Assess Symptom Burden in Sickle Cell Disease Open
Introduction Sickle cell disease (SCD) is a genetic vascular disease that causes pain, fatigue and multiple complications, ultimately affecting health-related quality of life of patients (Osunkwo et al. Am J Hematol 2021). The purpose of t…
View article: Impact of rifaximin use following an initial overt hepatic encephalopathy hospitalization on rehospitalization and costs
Impact of rifaximin use following an initial overt hepatic encephalopathy hospitalization on rehospitalization and costs Open
Initiation of rifaximin after an OHE hospitalization was associated with reduced OHE hospitalizations both in the 30-days following and annually. Further, reduced medical costs offset increased pharmacy costs, and no annual cost difference…
View article: Content validation of a daily patient-reported outcome measure for assessing symptoms in patients with Small Intestinal Bacterial Overgrowth
Content validation of a daily patient-reported outcome measure for assessing symptoms in patients with Small Intestinal Bacterial Overgrowth Open
Purpose The aim of this study was to generate evidence supporting the development and content validity of a new PRO instrument, the Small Intestinal Bacterial Overgrowth (SIBO) Symptom Measure (SSM) daily diary. The SSM assesses symptom se…
View article: Association of dyskalemias with short-term health care utilization in patients with advanced CKD
Association of dyskalemias with short-term health care utilization in patients with advanced CKD Open
BACKGROUND: Patients with advanced chronic kidney disease (CKD) are at high risk for dyskalemias, which may induce arrhythmias that require immediate emergent or hospital care. The association of dyskalemias with short-term hospital/emerge…
View article: Cannabis Use and Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease Transitioning to Dialysis
Cannabis Use and Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease Transitioning to Dialysis Open
Background: The current social and legal landscape is likely to foster the medicinal and recreational use of cannabis. Synthetic cannabinoid use is associated with acute kidney injury (AKI) in case reports; however, the association between…
View article: Laxative Use and Risk of Dyskalemia in Patients with Advanced CKD Transitioning to Dialysis
Laxative Use and Risk of Dyskalemia in Patients with Advanced CKD Transitioning to Dialysis Open
Significance Statement Intestinal potassium excretion is increased in patients with advanced CKD. It is possible that this compensatory mechanism is enhanced by laxative use, but little is known about the association of laxative use with r…
View article: Potassium Trajectories prior to Dialysis and Mortality following Dialysis Initiation in Patients with Advanced CKD
Potassium Trajectories prior to Dialysis and Mortality following Dialysis Initiation in Patients with Advanced CKD Open
Introduction: Patients with advanced non-dialysis-dependent CKD (NDD-CKD) have a reduced ability for maintaining plasma potassium (K) in normal range. Deviation from normal plasma K ranges is associated with increased mortality; however, t…
View article: Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis
Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis Open
Introduction: Hypo- and hyperkalemia are associated with a higher risk of ischemic stroke. However, this association has not been examined in an advanced chronic kidney disease (CKD) population. Methods: From among 102,477 US veterans tran…
View article: Poster Abstracts - Academy of Managed Care Pharmacy Nexus 2020
Poster Abstracts - Academy of Managed Care Pharmacy Nexus 2020 Open
The AMCP NEXUS 2020 VIRTUAL will be held online the week of October 19, 2020. The AMCP abstracts program provides a forum through which authors can share their insights and outcomes of advanced managed care practice. For NEXUS 2020 VIRTUAL…
View article: Association between Nrf2 and CDKN2A expression in patients with end-stage renal disease: a pilot study
Association between Nrf2 and CDKN2A expression in patients with end-stage renal disease: a pilot study Open
Patients with end-stage renal disease (ESRD) display phenotypic features of premature biological aging, characterized by disproportionately high morbidity and mortality at a younger age. Nuclear factor erythroid 2-related factor 2 (Nrf2) a…
View article: Laxative use in patients with advanced chronic kidney disease transitioning to dialysis
Laxative use in patients with advanced chronic kidney disease transitioning to dialysis Open
Background Constipation is highly prevalent in patients with chronic kidney disease (CKD), particularly among those with end-stage renal disease (ESRD), partly due to their dietary restrictions, comorbidities and medications. Laxatives are…
View article: Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Open
This study received no outside funding. Dashputre was recently employed by Novartis; K. Gatwood has received speaker fees from Jazz Pharmaceuticals; and J. Gatwood has received research funding from Merck & Co. and GlaxoSmithKline, unrelat…
View article: Cost-Effectiveness of Peginterferon Beta-1a and Alemtuzumab in Relapsing-Remitting Multiple Sclerosis
Cost-Effectiveness of Peginterferon Beta-1a and Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Open
No outside funding supported this study. Kamal has received research funding from Novartis Pharmaceuticals and the College of Psychiatric and Neurologic Pharmacists and also serves as a consultant for the Lynx Group. Dashputre and Pawar re…
View article: A Systematic Review of the Effect of Cancer Treatment on Work Productivity of Patients and Caregivers
A Systematic Review of the Effect of Cancer Treatment on Work Productivity of Patients and Caregivers Open
This study was funded by Novartis Pharmaceuticals, which provided the concept, general oversight, and research collaboration on the project. Covvey and Kamal received research funding from Novartis Pharmaceuticals and the College of Psychi…